CTMX : Insider Transactions for Cytomx Therapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Cytomx Therapeutics, Inc. (CTMX)

$0.00 0.00 (0.00%) as of 4:30 Fri 2/14

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

65,160,000

Market Cap:

N/A

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0 - $0

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -

Company Profile CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company. Co. is developing an antibody-based therapeutics created using its Probody® therapeutic technology platform. Co.'s products include: Praluzatamab ravtansine, which is an activated antibody-drug conjugates directed against CD166, a tumor target previously considered undruggable due to its high expression on normal tissues; CX-2029, which opens a therapeutic window for targeting CD71; Pacmilimab, which is a Probody therapeutic against PD-L1, a clinically and commercially validated cancer target; and BMS-986249 and BMS-986288, which is the Probody versions of ipilimumab.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	47,819	75,591	103,916	162,805
Total Sell Value	$99,726	$138,068	$174,902	$267,502
Total People Sold	5	5	5	8
Total Sell Transactions	5	10	14	26
End Date	2024-02-04	2023-11-03	2023-05-05	2022-05-05

Adjust Filter Settings

Records found: 286

Page 7 of 12

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Mccarthy Sean A.

President and CEO

• • –

2017-10-04

4

AS

$24.13

$461,366

D/D

(19,120)

4,245

-

Mccarthy Sean A.

President and CEO

• • –

2017-10-04

4

OE

$0.95

$18,068

D/D

19,120

23,365

-

Kavanaugh William Michael

CSO, Head Res.&Non-Clin. Dev.

• – –

2017-10-04

4

AS

$24.34

$1,177,277

D/D

(48,368)

13,917

-

Kavanaugh William Michael

CSO, Head Res.&Non-Clin. Dev.

• – –

2017-10-04

4

OE

$4.47

$216,340

D/D

48,368

62,285

-

Gluck Frederick W

Director

– • –

2017-10-04

4

AS

$24.27

$242,680

I/I

(10,000)

311,643

-

Tepper Robert I

10% Owner

– – •

2017-10-04

4

AS

$24.34

$603,072

D/D

(24,777)

29,516

-

Mccarthy Sean A.

President and CEO

• • –

2017-10-02

4

AS

$18.57

$177,566

D/D

(9,562)

4,245

-

Mccarthy Sean A.

President and CEO

• • –

2017-10-02

4

OE

$0.95

$9,036

D/D

9,562

13,807

-

Chief Financial Officer

• – –

2017-10-02

4

AS

$18.10

$45,250

D/D

(2,500)

14,626

-

Gluck Frederick W

Director

– • –

2017-09-26

4

AS

$17.30

$86,476

I/I

(5,000)

321,643

-

Tepper Robert I

10% Owner

– – •

2017-09-19

4

AS

$18.00

$360,000

D/D

(20,000)

54,293

-

Chief Financial Officer

• – –

2017-09-01

4

AS

$17.17

$42,925

D/D

(2,500)

17,126

-

Mccarthy Sean A.

President and CEO

• • –

2017-09-01

4

AS

$17.32

$171,988

D/D

(9,930)

4,245

-

Mccarthy Sean A.

President and CEO

• • –

2017-09-01

4

OE

$0.95

$9,384

D/D

9,930

14,175

-

Mccarthy Sean A.

President and CEO

• • –

2017-08-31

4

AS

$17.50

$328,260

D/D

(18,756)

4,245

-

Mccarthy Sean A.

President and CEO

• • –

2017-08-31

4

OE

$0.95

$17,724

D/D

18,756

23,001

-

Chief Financial Officer

• – –

2017-08-09

4

AS

$15.00

$37,500

D/D

(2,500)

19,626

-

Mccarthy Sean A.

President and CEO

• • –

2017-08-09

4

AS

$15.00

$71,715

D/D

(4,781)

4,245

-

Mccarthy Sean A.

President and CEO

• • –

2017-08-09

4

OE

$0.95

$4,518

D/D

4,781

9,026

-

Tepper Robert I

10% Owner

– – •

2017-07-13

4

AS

$0.00

$0

D/D

(850,000)

4,320,348

-

Mccarthy Sean A.

President and CEO

• • –

2017-07-03

4

AS

$15.52

$74,201

D/D

(4,781)

4,245

-

Mccarthy Sean A.

President and CEO

• • –

2017-07-03

4

OE

$0.95

$4,518

D/D

4,781

9,026

-

Chief Financial Officer

• – –

2017-07-03

4

AS

$15.47

$38,675

D/D

(2,500)

22,126

-

Tepper Robert I

10% Owner

– – •

2017-06-29

4

AS

$16.00

$240,000

D/D

(15,000)

44,777

-

Mccarthy Sean A.

President and CEO

• • –

2017-06-26

4

S

$15.00

$67,215

D/D

(4,481)

4,245

-

286 Records found	1 2 3 4 5 6 7 8 9 Next	Page 7 of 12

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.